NCT02890368
Trial of Intratumoral Injections of TTI-621 in Subjects With Relapsed and Refractory Solid Tumors and Mycosis Fungoides treatment 1 terminated NCT04616248
In Situ Immunomodulation With CDX-301, Radiation Therapy, CDX-1140 and Poly-ICLC in Patients w/ Unresectable and Metastatic Solid Tumors treatment 1 recruiting NCT04977453
GI-101 As a Single Agent or in Combination with Pembrolizumab, Lenvatinib or Local Radiotherapy in Advanced Solid Tumors treatment 1 / 2 recruiting NCT05078047
Study Comparing the Standard Administration of IO Versus the Same IO Administered Each 3 Months in Patients in Response After 6 Months of Standard IO No drug interventions treatment 3 recruiting NCT06056895
Triple Immune Checkpoint Inhibition for Advanced or Metastatic PD-(L)1 Refractory Merkel Cell Carcinoma treatment 2 recruiting NCT05594290
Chemo-immunotherapy in Patients With Resectable Merkel Cell Carcinoma Prior to Surgery treatment 2 recruiting NCT04853602
IFx-Hu2.0 Expanded Access Program Not Available Not Available available NCT04916002
A Trial To Find Out If Vidutolimod Together With Cemiplimab Is Safe And If It Works In Adult Participants With Advanced Cancer Or Metastatic Cancer treatment 2 active_not_recruiting NCT04260802
A Study to Evaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic Cancers treatment 1 / 2 recruiting NCT02054884
F16IL2 Plus Paclitaxel in Metastatic Merkel Cell Carcinoma treatment 2 terminated NCT02831179
Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine Tumor treatment 1 withdrawn NCT02819843
A Study of T-VEC (Talimogene Laherparepvec) With or Without Radiotherapy for Melanoma, Merkel Cell Carcinoma, or Other Solid Tumors treatment 2 completed NCT06039033
Exploring Merkel Cell Carcinoma Clinical Trial Engagement Patterns No drug interventions Not Available Not Available not_yet_recruiting NCT04393753
Domatinostat in Combination With Avelumab in Patients With Advanced Merkel Cell Carcinoma Progressing on Anti-PD-(L)1 treatment 2 completed NCT03652077
A Safety and Tolerability Study of INCAGN02390 in Select Advanced Malignancies treatment 1 completed NCT06008977
Exercise to Boost Response to Checkpoint Blockade Immunotherapy No drug interventions other Not Available recruiting NCT03370861
How Microbes and Metabolism May Predict Skin Cancer Immunotherapy Outcomes No drug interventions Not Available Not Available terminated NCT02196961
Adjuvant Therapy of Completely Resected Merkel Cell Carcinoma With Immune Checkpoint Blocking Antibodies vs Observation treatment 2 active_not_recruiting NCT03538028
A Safety and Tolerability Study of INCAGN02385 in Select Advanced Malignancies treatment 1 completed NCT03935893
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Advanced Solid Cancers treatment 2 recruiting NCT00765193
The Impact of Total Body Skin Examination on Skin Cancer Detection No drug interventions diagnostic Not Available completed NCT03783078
Pembrolizumab (MK-3475) as First-line Therapy for Advanced Merkel Cell Carcinoma (MK-3475-913) treatment 3 completed NCT03629756
A Study to Evaluate the Safety and Tolerability of Immunotherapy Combinations in Participants With Advanced Malignancies treatment 1 completed NCT00346385
BB-10901 in Treating Patients With Relapsed or Refractory Solid Tumors treatment 1 completed NCT04291885
Immunotherapy Adjuvant Trial in Patients With Stage I-III Merkel Cell Carcinoma treatment 2 recruiting NCT04157985
Evaluating Length of Treatment With PD-1/PD-L1 Inhibitor in Advanced Solid Tumors treatment 3 recruiting NCT04869137
Neoadjuvant Lenvatinib Plus Pembrolizumab in Merkel Cell Carcinoma treatment 2 recruiting NCT04975152
Neoadjuvant Cemiplimab in Newly Diagnosed or Recurrent Stage I-II Merkel Cell Carcinoma and Locoregionally Advanced Cutaneous Squamous Cell Carcinoma treatment 1 recruiting NCT03071406
Randomized Study of Nivolumab+Ipilimumab+/- SBRT for Metastatic Merkel Cell Carcinoma treatment 2 active_not_recruiting NCT06151236
Neoadjuvant Nivolumab and Relatlimab in Merkel Cell Carcinoma treatment 2 recruiting NCT02514824
MLN0128 in Recurrent/Metastatic Merkel Cell Carcinoma treatment 1 / 2 completed NCT01440816
IL-12 Gene and in Vivo Electroporation-Mediated Plasmid DNA Vaccine Therapy in Patients With Merkel Cell Cancer treatment 2 completed NCT03210935
French National Database of Rare Dermatological Cancers No drug interventions Not Available Not Available recruiting NCT01526486
Videoscopic Versus Open Inguinal Lymphadenectomy for Cancer No drug interventions treatment Not Available completed NCT06536257
Personalised Immunotherapy Platform No drug interventions Not Available Not Available recruiting NCT04160065
Immunotherapy With IFx-Hu2.0 Vaccine for Advanced Non-melanoma Skin Cancers treatment 1 active_not_recruiting NCT04116320
Focused Ultrasound Ablation and PD-1 Antibody Blockade in Advanced Solid Tumors treatment 1 active_not_recruiting NCT04874831
Domatinostat in Combination With Avelumab in Patients With Treatment-naïve Metastatic Merkel Cell Carcinoma (MERKLIN 1) treatment 2 withdrawn NCT04725331
A Clinical Trial Assessing BT-001 Alone and in Combination With Pembrolizumab in Metastatic or Advanced Solid Tumors treatment 1 / 2 recruiting NCT03901573
High-Risk Skin Cancers With Atezolizumab Plus NT-I7 treatment 1 / 2 terminated NCT05076760
MEM-288 Oncolytic Virus Alone and in Combination With Nivolumab in Solid Tumors Including Non-Small Cell Lung Cancer treatment 1 recruiting NCT05329792
L19IL2/L19TNF in Skin Cancer Patients treatment 2 recruiting NCT05086692
A Beta-only IL-2 ImmunoTherapY Study treatment 1 / 2 recruiting NCT05253144
Comparing Radical Surgery and Radical Radiotherapy as First Definitive Treatment for Primary MCC No drug interventions treatment Not Available completed NCT03228667
QUILT-3.055: A Study of Combination Immunotherapies in Patients Who Have Previously Received Treatment With Immune Checkpoint Inhibitors treatment 2 active_not_recruiting NCT04187872
LITT and Pembrolizumab in Recurrent Brain Metastasis treatment 1 terminated NCT00003514
Antineoplaston Therapy in Treating Patients With Neuroendocrine Tumor That Is Metastatic or Unlikely to Respond to Surgery or Radiation Therapy treatment 2 withdrawn NCT02643303
A Study of Tremelimumab and IV Durvalumab Plus Poly-ICLC in Subjects With Biopsy-accessible Cancers treatment 1 / 2 completed NCT03167164
QUILT-3.045: NANT Merkel Cell Carcinoma (MCC) Vaccine: Combination Immunotherapy in Subjects With MCC Who Have Progressed on or After PD-L1 Therapy treatment 1 / 2 withdrawn NCT03787602
Navtemadlin (KRT-232) With or Without Anti-PD-1/Anti-PD-L1 for the Treatment of Patients With Merkel Cell Carcinoma treatment 1 / 2 recruiting NCT06047379
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis treatment 1 / 2 recruiting NCT01013779
Merkel Positron Emission Tomography (PET) Protocol treatment 2 completed NCT04596033
TiTAN-1: Safety, Proliferation and Persistence of GEN-011 Autologous Cell Therapy treatment 1 terminated NCT04047251
A Study of FF-10850 Topotecan Liposome Injection in Advanced Solid Tumors Including Merkel Cell Carcinoma treatment 1 recruiting NCT03988647
Palliative RT & Anti-PD-1/PD-L1 Checkpoint Blockade in Metastatic Merkel Cell Carcinoma treatment 2 terminated NCT02479698
Cytotoxic T Lymphocytes in Treating Patients With Malignancies With BK and/or JC Virus No drug interventions treatment 2 recruiting NCT03583528
DOTATOC PET/CT for Imaging NET Patients No drug interventions Not Available Not Available recruiting NCT06448611
Identification and Characterization of Circulating Tumor Cells Before and After Treatment (Surgery and Radiotherapy) in a Cohort of Patients Treated for Resectable Stage I-III Merkel Cell Carcinoma No drug interventions Not Available Not Available not_yet_recruiting NCT05120271
BOXR1030 T Cells in Subjects With Advanced GPC3-Positive Solid Tumors treatment 1 / 2 recruiting NCT06086288
Study of PembrolizumAb combiNeD With Cisplatin or carbOplatin and Etoposide in Treatment naïve Advanced meRkel Cell cArcinoma (MCC) treatment 2 not_yet_recruiting NCT06223659
EMLA Topical Cream for Treatment of Pain in Patients Receiving Intra-Dermal Technetium 99 Injections for Lymphoscintigraphy for Skin Cancers treatment 2 recruiting NCT04242199
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099280 in Participants With Advanced Solid Tumors No drug interventions treatment 1 active_not_recruiting NCT05496036
Neoadjuvant PD-1 Blockade in Resectable Merkel Cell Carcinoma treatment 2 recruiting NCT04349436
A Phase 1B/2 Study of RP1 in Solid Organ Transplant Patients With Advanced Cutaneous Malignancies No drug interventions treatment 1 / 2 recruiting NCT04234113
Study of SO-C101 and SO-C101 in Combination With Pembro in Adult Patients With Advanced/Metastatic Solid Tumors treatment 1 active_not_recruiting NCT03458117
T-VEC in Non-melanoma Skin Cancer No drug interventions treatment 1 completed NCT03853317
QUILT-3.063: A Study of N-803, haNK and Avelumab in Patients With Merkel Cell Carcinoma That Has Progressed After Checkpoint Therapy treatment 2 terminated NCT04272034
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099318 in Participants With Advanced Solid Tumors No drug interventions treatment 1 active_not_recruiting NCT03545334
Lymph Node Identification in Skin Malignancy Using ICG Transcutaneously Study No drug interventions diagnostic Not Available completed NCT03798639
Nivolumab and Radiation Therapy or Ipilimumab as Adjuvant Therapy in Treating Patients With Merkel Cell Cancer treatment 1 completed NCT02978625
Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers treatment 2 active_not_recruiting NCT02035657
A Proof-of-Concept Trial of GLA-SE in Patients With Merkel Cell Carcinoma treatment 1 completed NCT06021626
A Study of CRD3874-SI in People With Solid Tumors No drug interventions treatment 1 recruiting NCT00540566
Optical Biopsy of Human Skin in Conjunction With Laser Treatment No drug interventions Not Available Not Available completed NCT05429866
Immunological Variables Associated to ICI Toxicity in Cancer Patients other 2 recruiting NCT05859074
A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer treatment 1 active_not_recruiting NCT04792073
Study of Avelumab and/or Radiation Therapy in People With Advanced Merkel Cell Carcinoma treatment 2 recruiting NCT02036476
Cabozantinib in Recurrent/Metastatic Merkel Cell Carcinoma treatment 2 terminated NCT01913691
Study of the Drug Ipilimumab for Metastatic Merkel Cell Carcinoma treatment 2 withdrawn NCT04705389
SerUM Markers in MERkel Cell Carcinoma Patients: a Longitudinal moniTorIng Study for optiMization of European Guidelines No drug interventions other Not Available unknown_status NCT03435640
REVEAL Study of NKTR-262 in Combination With NKTR-214 and Nivolumab in Patients With Locally Advanced / Metastatic Solid Tumor Malignancies treatment 1 / 2 terminated NCT04106167
Long-term, Non-interventional, Observational Study Following Treatment With Fate Therapeutics FT500 Cellular Immunotherapy No drug interventions Not Available Not Available terminated NCT03212404
Phase 1 Study of CK-301 (Cosibelimab) as a Single Agent in Subjects With Advanced Cancers treatment 1 recruiting NCT03841110
FT500 as Monotherapy and in Combination With Immune Checkpoint Inhibitors in Subjects With Advanced Solid Tumors treatment 1 completed NCT04590781
Safety and Efficacy of XmAb18087 ± Pembrolizumab in Advanced Merkel Cell Carcinoma or Extensive-stage Small Cell Lung Cancer treatment 1 / 2 terminated NCT05422781
Study To Evaluate The Safety, Tolerability And Immunogenicity Of 4 mg Of ITI-3000 In Patients With Polyomavirus-Positive Merkel Cell Carcinoma (MCC) No drug interventions treatment 1 completed NCT05100095
Hypofractionated Radiation Therapy for Merkel Cell Carcinoma No drug interventions treatment 2 recruiting NCT05583708
Phase II Study of Peptide Receptor Radionuclide Therapy in Combination With Immunotherapy for Patients With Merkel Cell Cancer treatment 2 suspended NCT05358938
Exercise to Boost Response to Checkpoint Blockade Immunotherapy treatment 0 active_not_recruiting NCT02351128
Treatment of Unresecable and/or Metastatic Merkel Cell Carcinoma by Somatostatine Analogues treatment 2 completed NCT02471352
Studies of Dermatologic Diseases Biospecimen Acquisition Protocol No drug interventions Not Available Not Available recruiting NCT02155647
Avelumab in Participants With Merkel Cell Carcinoma (JAVELIN Merkel 200) treatment 2 completed